A real-world study of the efficacy and tolerability of fremanezumab in migraine patients with a median follow-up of 14 months

Shiho Suzuki(Dokkyo University), Koichi Hirata(Japan Coal Energy Center), Keisuke Suzuki(NEC (Japan)), Hiroaki Fujita(Dokkyo Medical University), Tomohiko Shiina(Dokkyo Medical University), Mukuto Shioda(Dokkyo Medical University), Saro Kobayashi(Dokkyo Medical University), Ryotaro Hida(Dokkyo Medical University), Yasuo Haruyama(Dokkyo Medical University)
Neurological Research and Practice
June 3, 2025
Cited by 3


Related Papers